Presenter Bio: Dr. Michael Lutz is a seasoned international life sciences executive with a significant wealth of entrepreneurial and start-up experience from the diagnostic and biotechnology industries. Michael is supporting Osteolabs since a number of years related to strategic, business and clinical development. In the past, Michael served as CEO at HepaRegeniX, a clinical stage biotech company in the field of advanced liver diseases. Before that, he was CEO of several Life Sciences companies which he successfully established or built-up to a successful exit. Michael holds a Ph.D in bioorganic chemistry from the ETH Zurich (Switzerland) and currently also serves on the Board of several other life sciences companies in Germany, the UK, Italy and Denmark.